Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00850785 · ClinicalTrials.gov registry record · Phase 1
Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer
A Phase 1 study, sponsored by Providence Health & Services.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT00850785: Completed Phase 1 study, sponsored by Providence Health & Services.
NCT00850785 is a Phase 1 study that has completed, run by Providence Health & Services. The registered enrollment target is 6 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00850785, a Phase 1 study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
This is a pilot single institution study of DRibble vaccination + GM-CSF in patients with stage IIIB or IV NSCLC who have undergone 0-1 chemotherapy regimens for metastatic disease. The primary objective of this trial is to evaluate immune responses induced by autologous DRibble vaccine in vivo and in vitro and against autologous and allogeneic lung cancer cells.
Interventions
- BIOLOGICAL DRibble vaccine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2009-01 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
What the finished NCT00850785 record still lists
NCT00850785 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which DRibble vaccine is the first listed.
NCT00850785 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00850785 about?
NCT00850785 is a clinical study titled "Autologous Tumor DRibble Vaccine in Patients With Non-Small Cell Lung Cancer". This is a pilot single institution study of DRibble vaccination + GM-CSF in patients with stage IIIB or IV NSCLC who have undergone 0-1 chemotherapy regimens for metastatic disease. The primary objective of this trial is to evaluate immune responses induced by autologous DRibble vaccine in vivo and ...
What is the current status of trial NCT00850785?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2009-01. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00850785?
The interventions under investigation include: DRibble vaccine (BIOLOGICAL).
Who is sponsoring clinical trial NCT00850785?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00850785's enrollment target sits among peer trials
6 1974th of 2000 higher than 12 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia